Cargando…
Biomarkers of Renal Disease and Progression in Patients with Diabetes
Diabetes prevalence is increasing worldwide, mainly due to the increase in type 2 diabetes. Diabetic nephropathy occurs in up to 40% of people with type 1 or type 2 diabetes. It is important to identify patients at risk of diabetic nephropathy and those who will progress to end stage renal disease....
Autores principales: | Hojs, Radovan, Ekart, Robert, Bevc, Sebastjan, Hojs, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470213/ https://www.ncbi.nlm.nih.gov/pubmed/26239462 http://dx.doi.org/10.3390/jcm4051010 |
Ejemplares similares
-
Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy
por: Vodošek Hojs, Nina, et al.
Publicado: (2020) -
Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk
por: Piko, Nejc, et al.
Publicado: (2021) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Vodošek Hojs, Nina, et al.
Publicado: (2021) -
The Role of Oxidative Stress in Kidney Injury
por: Piko, Nejc, et al.
Publicado: (2023) -
Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
por: Petreski, Tadej, et al.
Publicado: (2020)